Strata Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$306K Sell
333
-7
-2% -$7.1K 0.08% 72
2025
Q4
$365K Buy
+340
New +$325K 0.1% 60
2025
Q3
Sell
-296
Closed -$231K 103
2025
Q2
$231K Sell
296
-115
-28% -$89.4K 0.06% 74
2025
Q1
$340K Sell
411
-232
-36% -$193K 0.11% 58
2024
Q4
$496K Sell
643
-15
-2% -$12.4K 0.16% 50
2024
Q3
$583K Buy
658
+35
+6% +$31.5K 0.19% 46
2024
Q2
$564K Sell
623
-711
-53% -$569K 0.19% 41
2024
Q1
$1.04M Buy
+1,334
New +$949K 0.37% 30

Other funds holding LLY

Strata Wealth Advisors's LLY Position: Q1 2026 in Review

Strata Wealth Advisors reduced its Eli Lilly (LLY) stake by 2.1% in Q1 2026, selling an estimated $7.1K and leaving 333 shares worth $306K. The position accounts for 0.08% of the portfolio, ranked #72.

Strata Wealth Advisors first reported a position in LLY in Q1 2024 and has held it in 8 quarters since. The position peaked at $1.04M in Q1 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Strata Wealth Advisors held 333 shares of Eli Lilly worth $306K as of Q1 2026.
  • Strata Wealth Advisors sold 7 Eli Lilly shares in Q1 2026, an estimated $7.1K.
  • Eli Lilly made up 0.08% of Strata Wealth Advisors's portfolio in Q1 2026, its #72 holding.
  • Strata Wealth Advisors first reported a position in Eli Lilly in Q1 2024 and has held it in 8 quarters since.
  • Strata Wealth Advisors's Eli Lilly position peaked at $1.04M in Q1 2024.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Strata Wealth Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.